BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6720529)

  • 1. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies.
    Cressman MD; Vidt DG; Gifford RW; Moore WS; Wilson DJ
    Am Heart J; 1984 May; 107(5 Pt 1):980-5. PubMed ID: 6720529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diazoxide and labetalol in acute hypertension during haemodialysis.
    Keusch G; Schiffl H; Binswanger U
    Eur J Clin Pharmacol; 1983; 25(4):523-7. PubMed ID: 6653648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.
    Pearson RM; Griffith DN; Woollard M; James IM; Havard CW
    Br J Clin Pharmacol; 1979; 8(Suppl 2):195S-198S. PubMed ID: 526401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diazoxide vs labetalol: a cross-over comparison of short-term effects in hypertension.
    Rumboldt Z; Bagatin J; Vidovic A
    Int J Clin Pharmacol Res; 1983; 3(1):47-54. PubMed ID: 6679507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
    Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
    Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind trial of labetalol.
    Kane J; Gregg I; Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labetalol in the difficult hypertensive patient in general practice.
    Harris C
    Curr Med Res Opin; 1978; 5(8):618-24. PubMed ID: 710176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
    Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of labetalol, clonidine and diazoxide intravenously administered in severe hypertension.
    Yeung CK; Thomas GW; Whitworth JA; Kincaid-Smith P
    Med J Aust; 1979 Nov; 2(9):499-500. PubMed ID: 522807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
    Michelson EL; Frishman WH
    Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monotherapy with labetalol for hypertensive patients with normal and impaired renal function.
    Thompson FD; Joekes AM; Hussein MM
    Br J Clin Pharmacol; 1979; 8(Suppl 2):129S-133S. PubMed ID: 526392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labetalol in hypertensive emergencies.
    MacCarthy EP; Frost GW; Stokes GS
    Med J Aust; 1978 Apr; 1(7):399-400. PubMed ID: 672732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of severe hypertension by repeated bolus injections of labetalol.
    Cumming AM; Brown JJ; Lever AF; Mackay A; Robertson JI
    Br J Clin Pharmacol; 1979; 8(Suppl 2):199S-204S. PubMed ID: 393288
    [No Abstract]   [Full Text] [Related]  

  • 16. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
    Michelson EL; Frishman WH; Lewis JE; Edwards WT; Flanigan WJ; Bloomfield SS; Johnson BF; Lucas C; Freis ED; Finnerty FA
    Am J Med; 1983 Oct; 75(4A):68-80. PubMed ID: 6356901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe hypertension with intravenous labetalol.
    Papademetriou V; Notargiacomo AV; Khatri IM; Freis ED
    Clin Pharmacol Ther; 1982 Oct; 32(4):431-5. PubMed ID: 7116758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labetalol infusion in hypertensive emergencies.
    Lebel M; Langlois S; Belleau LJ; Grose JH
    Clin Pharmacol Ther; 1985 Jun; 37(6):615-8. PubMed ID: 3891186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labetalol in essential hypertension.
    Larochelle P; Hamet P; Hoffman B; Kuchel O; McKenzie J; Mitenko P; Ogilvie RI; Ruedy J
    J Cardiovasc Pharmacol; 1980; 2(6):751-9. PubMed ID: 6160325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol in essential hypertension.
    Breckenridge A; Orme M; Serlin MJ; Maciver M
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):37S-39S. PubMed ID: 6124264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.